open access

Vol 29, No 1 (2022)
Research Letter
Submitted: 2021-07-16
Accepted: 2021-11-20
Published online: 2021-12-01
Get Citation

Pulmonary arterial hypertension and right ventricular systolic dysfunction in COVID-19 survivors

Rosario Rossi12, Francesca Coppi12, Daniel Enrique Monopoli1, Fabio Alfredo Sgura1, Salvatore Arrotti1, Giuseppe Boriani1
DOI: 10.5603/CJ.a2021.0159
·
Pubmed: 34897638
·
Cardiol J 2022;29(1):163-165.
Affiliations
  1. Division of Cardiology, University of Modena and Reggio Emilia (UNIMORE), Modena, Italy
  2. Pulmonary Hypertension Program, Azienda Ospedaliera Policlinico di Modena, Modena, Italy

open access

Vol 29, No 1 (2022)
Research letters — COVID-19
Submitted: 2021-07-16
Accepted: 2021-11-20
Published online: 2021-12-01

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Pulmonary arterial hypertension and right ventricular systolic dysfunction in COVID-19 survivors

Journal

Cardiology Journal

Issue

Vol 29, No 1 (2022)

Article type

Research Letter

Pages

163-165

Published online

2021-12-01

Page views

2095

Article views/downloads

466

DOI

10.5603/CJ.a2021.0159

Pubmed

34897638

Bibliographic record

Cardiol J 2022;29(1):163-165.

Authors

Rosario Rossi
Francesca Coppi
Daniel Enrique Monopoli
Fabio Alfredo Sgura
Salvatore Arrotti
Giuseppe Boriani

References (10)
  1. Belli S, Balbi B, Prince I, et al. Low physical functioning and impaired performance of activities of daily life in COVID-19 patients who survived hospitalisation. Eur Respir J. 2020; 56(4).
  2. Sigfrid L, Cevik M, Jesudason E, et al. What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19? A harmonised, global longitudinal observational study protocol. BMJ Open. 2021; 11(3): e043887.
  3. Moreno-Pérez O, Merino E, Leon-Ramirez JM, et al. COVID19-ALC research group. Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study. J Infect. 2021; 82(3): 378–383.
  4. Galiè N, McLaughlin VV, Rubin LJ, et al. An overview of the 6th World Symposium on Pulmonary Hypertension. Eur Respir J. 2019; 53(1).
  5. Patel BV, Arachchillage DJ, Ridge CA, et al. Pulmonary angiopathy in severe COVID-19: physiologic, imaging, and hematologic observations. Am J Respir Crit Care Med. 2020; 202(5): 690–699.
  6. Jha AK. Pulmonary vascular changes in acute respiratory distress syndrome due to COVID-19. Am J Respir Crit Care Med. 2021; 203(2): 259–260.
  7. Chen L, Tang R, Chen H, et al. Pulmonary vasculature: a target for COVID-19. Am J Respir Crit Care Med. 2021; 203(2): 260–261.
  8. Amsallem M, Boulate D, Aymami M, et al. Load adaptability in patients with pulmonary arterial hypertension. Am J Cardiol. 2017; 120(5): 874–882.
  9. Vonk-Noordegraaf A, Haddad F, Chin KM, et al. Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology. J Am Coll Cardiol. 2013; 62(25 Suppl): D22–D33.
  10. El Hajj MC, Viray MC, Tedford RJ. Right heart failure: a hemodynamic review. Cardiol Clin. 2020; 38(2): 161–173.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl